Exploring the Efficacy and Safety of Pembrolizumab in Relapsed and Refractory Pediatric Hodgkin's Lymphoma: Insights from the KHCC Experience
Year: 2025
Type: article
Abstract: Conclusion: Keytruda is effective in inducing CR in R/R HD patients, particularly as a bridging therapy to ABMT, with manageable toxicity.Achieving CR after Keytruda was associated with improved outcomes, and female patients showed a trend toward better responses.These findings support its use in this challenging patient population.
Source: OncoDaily Medical Journal
Authors: Faiha Bazzeh, Esraa Badarin, Iyad Sultan
Institution: King Hussein Cancer Center
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4409397860